Home/Filings/4/0001209191-19-052412
4//SEC Filing

Okuno Dale 4

Accession 0001209191-19-052412

CIK 0001006028other

Filed

Oct 2, 8:00 PM ET

Accepted

Oct 3, 6:30 PM ET

Size

7.3 KB

Accession

0001209191-19-052412

Insider Transaction Report

Form 4
Period: 2019-10-01
Okuno Dale
Director
Transactions
  • Purchase

    Common Stock

    2019-10-02$0.29/sh+862,068$250,0006,309,420 total
  • Award

    Stock Option (Right to Buy)

    2019-10-01+100,000100,000 total
    Exercise: $0.29Exp: 2029-10-01Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2020 or January 15, 2020 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2021 or January 15, 2021.

Issuer

PURE BIOSCIENCE, INC.

CIK 0001006028

Entity typeother

Related Parties

1
  • filerCIK 0001608989

Filing Metadata

Form type
4
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 6:30 PM ET
Size
7.3 KB